After the procedure is over, the representative should report the off-label use to the device manufacturer, even if an adverse event did not occur. The reason for this reporting is two-fold. First, reporting off-label use will alert the manufacturer to innovations in the medical field. The manufacturer may be able to use that information to have the device cleared for additional indications of use with the FDA, increasing the device's profitability. Second, the manufacturer needs to be aware of off-label uses of the device, because the manufacturer may be held liable for failure to warn about risks of off-label uses of which the manufacturer knew of or should have known.
Eric Zalud is chair of the Litigation Practice Group at Benesch, Friedlander, Coplan & Aronoff LLP. He focuses his practice on products liability matters including medical device defense.